Royal Philips Electronics and Immunetrics have entered into a joint development agreement to explore future-generation approaches to the problem of infectious disease in critical care. This announcement was made at the annual Congress of the Society of Critical Care Medicine, in Nashville, Tennessee.
The partnership unites Philips' strength in patient monitoring and the design and implementation of applications to help clinicians make more informed care decisions and Immunetrics' strengths in the dynamic modelling and simulation of complex biological systems. Under the joint development agreement, Philips Research and Immunetrics will study the combination of advanced bioinformatics and computer modelling to identify opportunities to reduce the incidence and improve the management of systemic infection, a major complicating factor among many critically ill patients.
Sepsis, a life-threatening, systemic inflammatory response to infection, is an example of a key medical challenge for which Philips Research and Immunetrics seek to develop new mechanisms for early and effective intervention.
